Britain's medicine and health-care regulator, the MHRA, gave emergency approval Wednesday for the COVID-19 vaccine made by Pfizer and BioNTech, making the U.K. the first country to green-light the promising vaccine for mass rollout. Britain has already ordered 40 million doses of the vaccine, or enough to inoculate 20 million people, and the first doses should arrive in the coming days. "Help is on its way," Health Secretary Matt Hancock tweeted: "The NHS stands ready to start vaccinating early next week."
Pfizer and fellow drugmaker Moderna have reported a 95 percent effectiveness rate for their vaccines from large human clinical trials. Both vaccines use a new approach, relying on messenger RNA, or mRNA, to teach the body how to fight off the new coronavirus. Moderna has also applied for emergency use authorization in Britain and the U.S., and the U.S. Food and Drug Administration is expected to approve both vaccines in the next two or three weeks. White House Chief of Staff Mark Meadows summoned FDA Commissioner Stephen Hahn to the West Wing on Tuesday to explain why the FDA hasn't already approved Pfizer's vaccine, Axios reports.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Wes Anderson: The Archives – ‘quirkfest’ celebrates the director’s ‘impeccable craft’The Week Recommends Retrospective at the Design Museum showcases 700 props, costumes and set designs from the filmmaker’s three-decade career
-
Is conscription the answer to Europe’s security woes?Today's Big Question How best to boost troop numbers to deal with Russian threat is ‘prompting fierce and soul-searching debates’
-
All My Sons: ‘epic and timeless’ theatre starring Bryan CranstonThe Week Recommends Ivo van Hove’s production of Arthur Miller’s classic play assumes the ‘grim yet towering momentum’ of a Greek tragedy
-
US mints final penny after 232-year runSpeed Read Production of the one-cent coin has ended
-
Warner Bros. explores sale amid Paramount bidsSpeed Read The media giant, home to HBO and DC Studios, has received interest from multiple buying parties
-
Gold tops $4K per ounce, signaling financial uneaseSpeed Read Investors are worried about President Donald Trump’s trade war
-
Electronic Arts to go private in record $55B dealspeed read The video game giant is behind ‘The Sims’ and ‘Madden NFL’
-
New York court tosses Trump's $500M fraud fineSpeed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in IntelSpeed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
-
US to take 15% cut of AI chip sales to ChinaSpeed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
NFL gets ESPN stake in deal with DisneySpeed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
